TY - JOUR
T1 - Clinicopathological Characteristics of Superficial Barrett's Adenocarcinoma in a Japanese Population
T2 - A Retrospective, Multicenter Study
AU - Hamada, Kenta
AU - Kanzaki, Hiromitsu
AU - Miyahara, Koji
AU - Nakagawa, Masahiro
AU - Mouri, Hirokazu
AU - Mizuno, Motowo
AU - Takahashi, Sakuma
AU - Hori, Shinichiro
AU - Nasu, Junichiro
AU - Tsuzuki, Takao
AU - Miyaike, Jiro
AU - Takenaka, Ryuta
AU - Yamauchi, Kenji
AU - Kobayashi, Sayo
AU - Toyokawa, Tatsuya
AU - Inoue, Masafumi
AU - Nishimura, Mamoru
AU - Matsubara, Minoru
AU - Tomoda, Jun
AU - Yamasaki, Yasushi
AU - Tanaka, Takehiro
AU - Shirakawa, Yasuhiro
AU - Kawahara, Yoshiro
AU - Fujiwara, Toshiyoshi
AU - Okada, Hiroyuki
N1 - Publisher Copyright:
© 2022 Japanese Society of Internal Medicine. All rights reserved.
PY - 2022
Y1 - 2022
N2 - Objective Although Barrett's adenocarcinoma (BA) remains a minor disease in Japan, its incidence has been gradually increasing. We analyzed the characteristics of BA in Japanese populations. Methods We retrospectively reviewed medical records and analyzed the clinicopathological differences between short-segment Barrett's esophagus (SSBE) and long-segment Barrett's esophagus (LSBE), as well as metastasis. Local recurrence and metachronous lesions were analyzed only in patients who underwent endoscopic resection (ER). Patients Consecutive patients who had pathological T1 BAs resected by ER or surgery from January 2003 to December 2017. Results A total of 168 patients were analyzed, including 139 with SSBE and 29 with LSBE. In total, 67% of the SSBE lesions and 32% of the LSBE lesions were located between 0 and 3 o'clock (p=0.0014). No patients who achieved pathological margin-free resection (pR0) and 17% of patients who did not achieve pR0 experienced local recurrence (p=0.0131). None of the patients without lymphovascular involvement, a poorly differentiated component, lesion size of >30 mm, and submucosal invasion of >500 μm experienced metastasis. The 5-year cumulative incidence rate of metachronous BA after ER was 0% in patients with SSBE and 40% in patients with LSBE (p=0.0005). Conclusion Superficial BA was likely to be detected at the right anterior wall of SSBE in the Japanese population. The risk for metachronous BA after ER was high in Japanese patients with LSBE, as in Western patients.
AB - Objective Although Barrett's adenocarcinoma (BA) remains a minor disease in Japan, its incidence has been gradually increasing. We analyzed the characteristics of BA in Japanese populations. Methods We retrospectively reviewed medical records and analyzed the clinicopathological differences between short-segment Barrett's esophagus (SSBE) and long-segment Barrett's esophagus (LSBE), as well as metastasis. Local recurrence and metachronous lesions were analyzed only in patients who underwent endoscopic resection (ER). Patients Consecutive patients who had pathological T1 BAs resected by ER or surgery from January 2003 to December 2017. Results A total of 168 patients were analyzed, including 139 with SSBE and 29 with LSBE. In total, 67% of the SSBE lesions and 32% of the LSBE lesions were located between 0 and 3 o'clock (p=0.0014). No patients who achieved pathological margin-free resection (pR0) and 17% of patients who did not achieve pR0 experienced local recurrence (p=0.0131). None of the patients without lymphovascular involvement, a poorly differentiated component, lesion size of >30 mm, and submucosal invasion of >500 μm experienced metastasis. The 5-year cumulative incidence rate of metachronous BA after ER was 0% in patients with SSBE and 40% in patients with LSBE (p=0.0005). Conclusion Superficial BA was likely to be detected at the right anterior wall of SSBE in the Japanese population. The risk for metachronous BA after ER was high in Japanese patients with LSBE, as in Western patients.
KW - Barrett's adenocarcinoma
KW - endoscopic resection
KW - long-segment Barrett's esophagus
KW - metachronous lesion
KW - short-segment Barrett's esophagus
KW - surgery
UR - http://www.scopus.com/inward/record.url?scp=85128373514&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128373514&partnerID=8YFLogxK
U2 - 10.2169/internalmedicine.6942-20
DO - 10.2169/internalmedicine.6942-20
M3 - Article
C2 - 35431302
AN - SCOPUS:85128373514
SN - 0918-2918
VL - 61
SP - 1115
EP - 1123
JO - Internal Medicine
JF - Internal Medicine
IS - 8
ER -